TAVI with BAV | TAVI without BAV | OR (95% CI) | ||||
---|---|---|---|---|---|---|
N | % | N | % | Not-adjusted | Adjusteda | |
Death (%) | 327 | 1.8 | 343 | 1.5 | 0.79 (0.23–2.65) | 0.4 (0.06–1.86) |
Stroke (%) | 327 | 0.9 | 341 | 0.3 | 0.32 (0.02–2.5) | 0.79 (0.02–27.7) |
Non-fatal MI (%) | 336 | 0.6 | 349 | 0.9 | 1.45 (0.24–11.05) | 1.29 (0.12–13.1) |
New-onset dialysis (%) | 332 | 3.9 | 348 | 3.7 | 0.95 (0.43–2.1) | 0.97 (0.4–2.32) |
Creatinine increase (%) | 268 | 1.5 | 210 | 1.4 | 0.96 (0.19–4.38) | 0.42 (0.02–3.22) |
Permanent pacemaker implantation (%) | 337 | 10.1 | 350 | 8.6 | 0.84 (0.5–1.4) | 1.17 (0.62–2.2) |
Life-threatening bleeding (%) | 333 | 3.0 | 345 | 1.4 | 0.48 (0.15–1.35) | 0.42 (0.09–1.48) |
Major vascular complications (%) | 333 | 4.5 | 345 | 3.5 | 0.76 (0.35–1.66) | 0.63 (0.21–1.65) |
Hospitalization (%) | 333 | 2.7 | 344 | 1.2 | 0.42 (0.11–1.31) | 0.48 (0.09–1.9) |
Valve dysfunction (%) | 322 | 0.9 | 337 | 0.0 | – | – |
NYHA Class III or IV (%) | 336 | 54.5 | 346 | 17.6 | 0.18 (0.13–0.25) | 0.18 (0.12–0.27) |
CCS grading of angina pectoris Class III or IV (%) | 308 | 1.6 | 296 | 1.0 | 0.62 (0.13–2.55) | 0.98 (0.18–4.8) |